Last reviewed · How we verify
Topical treatments or phototherapy
Topical treatments or phototherapy is a Small molecule drug developed by Amgen. It is currently in Phase 3 development for Psoriasis, Vitiligo. Also known as: Corticosteroid creams, Light Therapy.
Phototherapy uses specific wavelengths of light to target and treat skin conditions.
Phototherapy uses specific wavelengths of light to target and treat skin conditions. Used for Psoriasis, Vitiligo.
At a glance
| Generic name | Topical treatments or phototherapy |
|---|---|
| Also known as | Corticosteroid creams, Light Therapy |
| Sponsor | Amgen |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Phototherapy works by targeting specific cells or molecules in the skin, leading to the reduction of inflammation and other symptoms associated with skin conditions. This can be achieved through various mechanisms, including the activation of certain enzymes or the inhibition of others.
Approved indications
- Psoriasis
- Vitiligo
Common side effects
- Skin irritation
- Eye damage
Key clinical trials
- Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics (NA)
- Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
- Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) (NA)
- Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses (PHASE2)
- Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp (PHASE3)
- Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction (PHASE3)
- Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas (PHASE1)
- Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical treatments or phototherapy CI brief — competitive landscape report
- Topical treatments or phototherapy updates RSS · CI watch RSS
- Amgen portfolio CI
Frequently asked questions about Topical treatments or phototherapy
What is Topical treatments or phototherapy?
How does Topical treatments or phototherapy work?
What is Topical treatments or phototherapy used for?
Who makes Topical treatments or phototherapy?
Is Topical treatments or phototherapy also known as anything else?
What development phase is Topical treatments or phototherapy in?
What are the side effects of Topical treatments or phototherapy?
Related
- Manufacturer: Amgen — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Psoriasis
- Indication: Drugs for Vitiligo
- Also known as: Corticosteroid creams, Light Therapy
- Compare: Topical treatments or phototherapy vs similar drugs
- Pricing: Topical treatments or phototherapy cost, discount & access